Effects of Retinoic Acid on the Expressions of Vangl1 and Vangl2 in Mouse Fetuses

References

• Agnish N. D., Kochhar D. M. Developmental toxicology of retinoids. Retinoids in clinical practice, G. Koren. Dekker, New York 1992; 47–76
   Google Scholar
• Centers for Disease Control and Prevention. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm. Rep. 41(RR-14), 1–7.
   Google Scholar
• Copp A. J., Greene N. D., Murdoch J. N. The genetic basis of mammalian neurulation. Nat. Rev. Genet. 2003; 4(10)784–793
   PubMedGoogle Scholar
• Dencker L., D'Argy R., Danielsson B. R., Ghantous H., Sperber G. O. Saturable accumulation of retinoic acid in neural and neural crest derived cells in early embryonic development. Dev. Pharmacol. Ther. 1987; 10(13)212–223
   PubMedGoogle Scholar
• Detrait E. R., George T. M., Etchevers H. C., Gilbert J. R., Vekemans M., Speer M. C. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol. Teratol 2005; 27(3)515–524
   PubMed Web of Science ®Google Scholar
• Doudney K., Ybot-Gonzalez P., Paternotte C., Stevenson R. E., Greene N. D., Moore G. E., Copp A. J., Stanier P. Analysis of the planar cell polarity gene Vangl2 and its co-expressed paralogue Vangl1 in neural tube defect patients. Am. J. Med. Genet.. A. 2005; 136(1)90–92
   PubMedGoogle Scholar
• Fantel A. G., Shepard T. H., Newell-Morris L. L., Moffett B. C. Teratogenic effects of retinoic acid in pigtail monkeys (Macaca nemestrina). I. General features. Teratology 1977; 15(1)65–71
   PubMedGoogle Scholar
• Harland R. M. In situ hybridization: an improved whole-mount method for Xenopus embryos. Methods Cell Biol. 1991; 36: 685–695
   PubMed Web of Science ®Google Scholar
• Harnish D. C., Jiang H., Soprano K. J., Kochhar D. M., Soprano D. R. Retinoic acid receptor β2 mRNA is elevated by retinoic acid in vivo in susceptible regions of mid-gestation mouse embryos. Dev. Dyn. 1992; 194(3)239–246
   PubMedGoogle Scholar
• Iulianella A, Lohnes D. Contribution of retinoic acid receptor gamma to retinoid-induced craniofacial and axial defects. Dev. Dyn. 1997; 209(1)92–104
   PubMedGoogle Scholar
• Jessen J. R., Solnica-Krezel L. Identification and developmental expression pattern of van gogh-like 1, a second zebrafish strabismus homologue. Gene Expr. Patterns 2004; 4(3)339–344
   PubMedGoogle Scholar
• Kalter H. The teratogenic effects of hypervitaminosis A upon the face and mouth of inbred mice. Ann. NY Acad. Sci. 1960; 85: 42–55
   PubMed Web of Science ®Google Scholar
• Katoh Y., Katoh M. Comparative genomics on Vangl1 and Vangl2 genes. Int. J. Oncol. 2005; 26(5)1435–1440
   PubMedGoogle Scholar
• Kibar Z., Vogan K. J., Groulx N., Justice M. J., Underhill D. A., Gros P. Ltap, a mammalian homolog of Drosophila Strabismus/Van Gogh, is altered in the mouse neural tube mutant Loop-tail. Nat. Genet. 2001; 28(3)251–255
   PubMedGoogle Scholar
• Kistler A. Teratogenesis of retinoic acid in rats: susceptible stages and suppression of retinoic acid-induced limb malformations by cycloheximide. Teratology 1981; 23(1)25–31
   PubMedGoogle Scholar
• Li Z., Ren A., Zhang L., Ye R., Li S., Zheng J., Hong S., Wang T., Li Z. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res. A Clin. Mol. Teratol. 2006; 76(4)237–240
   PubMedGoogle Scholar
• Lohnes D., Kastner P., Dierich A., Mark M., LeMeur M., Chambon P. Function of retinoic acid receptor gamma in the mouse. Cell 1993; 73(4)643–658
   PubMed Web of Science ®Google Scholar
• Kibar Z., Torban E., McDearmid J. R., Reynolds A., Berghout J., Mathieu M., Kirillova I., De Marco P., Merello E., Hayes J. M., Wallingford J. B., Drapeau P., Capra V., Gros P. Mutations in VANGL1 associated with neural-tube defects. N Engl J Med 2007; 356(14)1432–1437
   PubMed Web of Science ®Google Scholar
• Milunsky, A., Jick, H., Jick, S.S., Bruell, C.L., MacLaughlin, D.S., Rothman, K.J., & Willett, W. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 263(20), 2747–2749.
   PubMedGoogle Scholar
• Vitamin Study Research Group., MRC. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338(8760)131–137
   PubMedGoogle Scholar
• Murdoch J. N., Doudney K., Paternotte C., Copp A. J., Stanier P. Severe neural tube defects in the loop-tail mouse result from mutation of Lpp1, a novel gene involved in floor plate specification. Hum. Mol. Genet. 2001; 10(22)2593–2601
   PubMedGoogle Scholar
• Seegmiller R. E., Ford W. H., Carter M. W., Mitala J. J., Powers W. J., Jr. A developmental toxicity study of tretinoin administered topically and orally to pregnant Wistar rats. J. Am. Acad. Dermatol. 1997; 36(3 Pt 2)S60–66
   Google Scholar
• Soprano D. R., Soprano K. J. Retinoids as teratogens. Annu. Rev. Nutr. 1995; 15: 111–132
   PubMed Web of Science ®Google Scholar
• Torban E., Wang H. J., Groulx N., Gros P. Independent mutations in mouse Vangl2 that cause neural tube defects in loop-tail mice impair interaction with members of the Dishevelled family. J. Biol. Chem. 2004; 279(50)52703–52713
   PubMedGoogle Scholar
• Wessely O., Tran U., Zakin L., De Robertis E. M. Identification and expression of the mammalian homologue of Bicaudal-C. Mech. Dev. 2001; 101(1–2)267–270
   PubMedGoogle Scholar
• Zhang Y., Liu K., Gao Y., Li S. Modulation of Dishevelled and Vangl2 by all-trans-retinoic acid in the developing mouse central nervous system and its relationship to teratogenesis. Acta Biochim. Biophys. Sin. (Shanghai) 2007; 39(9)684–692
   PubMedGoogle Scholar